Globe Life Inc. · GL · FY2025 Q4 · Calendar Q1 2026

Globe Life raises 2026 outlook as health premiums accelerate

Globe Life's Q4 analysis supports a constructive operating trajectory: accelerating health premiums, technology-enabled productivity, and raised 2026 guidance outweigh the near-term concerns identified in the call, though the thesis depends on lapse trends, health margins, interest rates, and successful reinsurance execution.

Why did GL rise 1.5% after missing EPS estimates in FY2025 Q4?

Research this report with FN2. Free to start; review your question before sending.

Reported After market closeNYSEFinancial Services $12.94B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $3.39 Consensus $3.44
EPS surprise -1.5% Reported versus consensus
Reported revenue $1.52B Consensus $1.53B
Revenue surprise -0.8% Reported versus consensus
Check the math in the surprise calculator >

Market reaction

event-close to next-session close
Stock move +1.5% Event window
SPY move -1.2% Same window
Abnormal move +2.7% Stock minus SPY
Volume 1.7× Versus trailing sessions
Subsequent drift -3.2% Up to 20 sessions
GLSPY benchmark

Ask FN2 about GL FY2025 Q4

Choose a question to continue your research

Free to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.

Transcript intelligence

What changed

The quarter added evidence of accelerating health premium growth and improved agent productivity, while management raised 2026 guidance and described further Bermuda reinsurance expansion. The call also highlighted the portfolio's unrealized bond loss and ongoing lapse, claims, and regulatory risks.

Guidance delta

Management raised 2026 guidance to EPS of $14.95-$15.65 and premium revenue growth of 7%-8%; higher health margins are expected.

Key takeaways

  • Q4 net income was $266 million, with operating income above guidance.
  • Health premium revenue accelerated on Medicare Supplement rate increases, while life premium growth remained steady.
  • Technology investments improved agent productivity despite a slight decline in agent count.
  • Management launched a Bermuda reinsurance affiliate and plans to expand reinsured business over the next three to five years.
  • The investment portfolio includes a $1.2 billion unrealized loss on long-duration bonds, which management said it is comfortable holding to maturity.

Management priorities

  • Increase exclusive-agency leads by about 10% in 2026.
  • Continue technology investments for agent productivity and direct-to-consumer conversion.
  • Implement agent-retention incentive programs in early 2026.
  • Expand Bermuda reinsurance transactions and pursue early reciprocal-jurisdiction status.
  • Invest in fixed-maturity bonds and commercial mortgage or limited-partnership investments.

Follow GL with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
GL REVENUE earnings history estimate and actual scatter chart 10 reported fiscal quarters and 4 future estimate-only quarters. Q4 '23 actual $1B, None Q1 '24 estimate $1B Q1 '24 actual $1B, miss Q2 '24 estimate $1B Q2 '24 actual $1B, miss Q3 '24 estimate $1B Q3 '24 actual $1B, miss Q2 '25 estimate $2B Q2 '25 actual $1B, miss Q3 '25 estimate $2B Q3 '25 actual $2B, miss Q4 '25 estimate $2B Q4 '25 actual $2B, miss Q1 '26 estimate $2B Q1 '26 actual $2B, miss Q2 '26 estimate $2B Q2 '26 actual $2B, beat Q3 '26 estimate $2B Q3 '26 actual $2B, beat Q4 '26 estimate $2B Q1 '27 estimate $2B Q2 '27 estimate $2B Q3 '27 estimate $2B
Show less

Analyst Consensus ?

ConsensusHold28 ratings
Bullish932.1%
Neutral1242.9%
Bearish725.0%

Analyst 52W Price Targets

$151.65Current
$90Low
$162.06Average
$215High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 22, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Wells Fargo Overweight OverweightMaintainOct 26, 2026
TD Cowen Buy BuyMaintainOct 23, 2026
Piper Sandler Neutral OverweightDowngradeOct 23, 2026
Evercore ISI Group In Line In LineMaintainOct 23, 2026
JP Morgan Overweight OverweightMaintainOct 15, 2026
Show 23 more rating actions

Named analyst price targets

Upside is calculated against the persisted current price $151.65. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Raymond JamesWilma Burdis$208$161.8 +37.2%Nov 12, 2026
KBWAnalyst unavailable$182$156.82 +20.0%Oct 26, 2026
Wells FargoWesley Carmichael$180$154.79 +18.7%Oct 26, 2026
TD CowenAnalyst unavailable$215$154.79 +41.8%Oct 23, 2026
UBSAnalyst unavailable$165$168.41 +8.8%Oct 23, 2026
See 33 more

Track every rating change on GL the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Globe Life Inc. delivers diverse life insurance and supplementary health coverage, alongside annuity products, targeting households in the lower-middle to middle-income brackets throughout the United States. The company's operations are structured into four key segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. Its offerings encompass whole life, term life, and other life protection plans; supplemental health benefits like Medicare supplements, critical illness, and accident policies; and both single-premium and flexible-premium deferred annuities. Founded in 1979 and headquartered in McKinney, Texas, the enterprise rebranded from Torchmark Corporation to Globe Life Inc. in August 2019.

Historical context

All GL earnings

Financial Services peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the GL recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
  2. FN2 earnings calendar · 2026-07-26T00:37:12.209961+00:00
  3. Polygon adjusted daily market bars · 2026-09-29T05:00:59.616922+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-29T05:00:59.613882+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-09-29. For educational purposes only; not investment advice.